CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sept. 16, 2008--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by UBS on Tuesday, September 23, 2008 at 12:30 p.m. EDT. The presentation will be webcast from the Grand Hyatt Hotel in New York City and may be accessed under the investor relations tab at www.alkermes.com. The presentation will be archived for 14 days.
Alkermes, Inc., a biotechnology company committed to developing innovative medicines to improve patients' lives, manufactures RISPERDAL(R) CONSTA(R) for schizophrenia and developed and manufactures VIVITROL(R) for alcohol dependence. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research and manufacturing facilities in Massachusetts and Ohio.
CONTACT: Alkermes, Inc.
Eva Stroynowski, 617-583-6823
Corporate Communications
SOURCE: Alkermes